FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
The Puutu Kunti Kurrama and Pinikura (PKKP) Aboriginal Corporation and Rio Tinto PLC (LON:RIO) have agreed to create the Juukan Gorge Legacy Foundation after signing a remedy agreement regarding the..
Kingfisher plc (LON:KGF) has provided its Q3 22/23 sales. Key points · Third quarter sales of £3.3bn; total sales +1.7% in constant currency and LFL +0.2% · Sales significantly ahead of pre-pandemic..
Intertek Group plc (LON:ITRK), a leading Total Quality Assurance provider to industries worldwide, has released its November Trading Update for the period from 1 January to 31 October 2022. All..
Severn Trent plc (LON:SVT) has announced its interim results for the six months to 30 September 2022. Robust financial performance, supported by strong cost control · Guiding to double-digit real..
Fresnillo plc (LON:FRES) has provided an update on the success of the additional testing requested by the state-owned power company, CFE (Comisión Federal de Electricidad). The testing to verify compatibility..
Endeavour Mining plc (LON:EDV) has announce that a major discovery has been made at its 100%-owned Tanda-Iguela greenfield exploration property in Côte d’Ivoire. The Tanda-Iguela property has the potential to..
Compass Group plc (LON:CPG) has announced its full year results announcement for the year ended 30 September 2022. Underlying1 results2022 Underlying1 results2021 Underlying1 resultsChange Statutory results2022 Statutory results2021 Statutory resultsChange..
DS Smith Plc (LON:SMDS) has announced the appointment of Richard Pike to the Company’s Board as Group Finance Director and Executive Director with effect from Adrian Marsh’s retirement next summer...
Legal & General Group Plc (LON:LGEN) has noted the Chancellor’s references in yesterday’s Autumn Statement to Solvency II reform. We believe the proposals represent a positive step forward. We also..
Burberry Group plc (LON:BRBY) has announced its interim results. “Burberry has an extraordinary legacy, a unique British heritage and a very strong platform to build on, as shown in our..
Convatec Group plc (LON:CTEC) will host a Capital Markets Event this afternoon, 17 November 2022. Convatec’s Executive Leadership Team, including Chief Executive Officer, Karim Bitar, and Chief Financial Officer, Jonny..
SSE plc (LON:SSE) has announced its interim results for the six months to 30 September 2022. NAVIGATING VOLATILITY TO DELIVER CRITICAL ENERGY INFRASTRUCTURE AND A STRONG PERFORMANCE · Investing at record..
BAE Systems plc (LON:BA) has provided a market update. Trading Update Key Points: · Strong order intake continuing – further £10bn secured in the second half to date · Good operational performance..
Land Securities Group PLC (LON:LAND) has announced results for the half year ended 30 September 2022. Mark Allan, Chief Executive of Landsec, commented: “The strategy we launched two years ago..
Vodafone Group Plc (LON:VOD) has announced its H1 FY23 results. Resilient performance in Europe & Africa, good progress on operational & portfolio priorities · Group service revenue growth of 2.5%* in..
Sage Group plc (LON:SGE) has announced the appointment of Maggie Chan Jones to its Board as a Non-executive Director with effect from 1 December 2022. Maggie is the founder and..
Informa plc (LON:INF), the international Academic Markets, B2B Markets and Digital Services Group, has issued its November Trading Statement. Stephen A. Carter, Group Chief Executive, Informa PLC, said: B2B market..
AstraZeneca plc (LON:AZN) Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adult patients with unresectable or metastatic biliary tract cancer..
AstraZeneca plc (LON:AZN) Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small..
GSK plc (LON/NYSE: GSK) has provided an update that at the request of the US Food and Drug Administration (FDA) it will restrict the second-line maintenance indication for Zejula (niraparib)..
